165 related articles for article (PubMed ID: 21176913)
1. Selective and self-guided micro-ablation of tissue with plasmonic nanobubbles.
Lukianova-Hleb EY; Koneva II; Oginsky AO; La Francesca S; Lapotko DO
J Surg Res; 2011 Mar; 166(1):e3-13. PubMed ID: 21176913
[TBL] [Abstract][Full Text] [Related]
2. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles.
Lukianova-Hleb E; Hu Y; Latterini L; Tarpani L; Lee S; Drezek RA; Hafner JH; Lapotko DO
ACS Nano; 2010 Apr; 4(4):2109-23. PubMed ID: 20307085
[TBL] [Abstract][Full Text] [Related]
3. Tunable plasmonic nanobubbles for cell theranostics.
Lukianova-Hleb EY; Hanna EY; Hafner JH; Lapotko DO
Nanotechnology; 2010 Feb; 21(8):85102. PubMed ID: 20097970
[TBL] [Abstract][Full Text] [Related]
4. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.
Wagner DS; Delk NA; Lukianova-Hleb EY; Hafner JH; Farach-Carson MC; Lapotko DO
Biomaterials; 2010 Oct; 31(29):7567-74. PubMed ID: 20630586
[TBL] [Abstract][Full Text] [Related]
5. Generation and detection of plasmonic nanobubbles in zebrafish.
Lukianova-Hleb EY; Santiago C; Wagner DS; Hafner JH; Lapotko DO
Nanotechnology; 2010 Jun; 21(22):225102. PubMed ID: 20453288
[TBL] [Abstract][Full Text] [Related]
6. Transient photothermal spectra of plasmonic nanobubbles.
Lukianova-Hleb EY; Sassaroli E; Jones A; Lapotko DO
Langmuir; 2012 Mar; 28(10):4858-66. PubMed ID: 22339620
[TBL] [Abstract][Full Text] [Related]
7. Laser pulse duration is critical for the generation of plasmonic nanobubbles.
Lukianova-Hleb EY; Volkov AN; Lapotko DO
Langmuir; 2014 Jul; 30(25):7425-34. PubMed ID: 24916057
[TBL] [Abstract][Full Text] [Related]
8. Optically guided controlled release from liposomes with tunable plasmonic nanobubbles.
Anderson LJ; Hansen E; Lukianova-Hleb EY; Hafner JH; Lapotko DO
J Control Release; 2010 Jun; 144(2):151-8. PubMed ID: 20156498
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles.
Lukianova-Hleb EY; Kim YS; Belatsarkouski I; Gillenwater AM; O'Neill BE; Lapotko DO
Nat Nanotechnol; 2016 Jun; 11(6):525-532. PubMed ID: 26878142
[TBL] [Abstract][Full Text] [Related]
10. Tunable plasmonic nanoprobes for theranostics of prostate cancer.
Lukianova-Hleb EY; Oginsky AO; Samaniego AP; Shenefelt DL; Wagner DS; Hafner JH; Farach-Carson MC; Lapotko DO
Theranostics; 2011 Jan; 1():3-17. PubMed ID: 21547151
[TBL] [Abstract][Full Text] [Related]
11. Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.
Lukianova-Hleb EY; Samaniego AP; Wen J; Metelitsa LS; Chang CC; Lapotko DO
J Control Release; 2011 Jun; 152(2):286-93. PubMed ID: 21315120
[TBL] [Abstract][Full Text] [Related]
12. Methods for Generation and Detection of Nonstationary Vapor Nanobubbles Around Plasmonic Nanoparticles.
Lukianova-Hleb EY; Lapotko DO
Methods Mol Biol; 2017; 1530():165-192. PubMed ID: 28150203
[TBL] [Abstract][Full Text] [Related]
13. Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors.
Lukianova-Hleb EY; Ren X; Townley D; Wu X; Kupferman ME; Lapotko DO
Theranostics; 2012; 2(10):976-87. PubMed ID: 23139725
[TBL] [Abstract][Full Text] [Related]
14. Method for disruption and re-canalization of atherosclerotic plaques in coronary vessels with photothermal bubbles generated around gold nanoparticles.
Lukianova-Hleb EY; Mrochek AG; Lapotko DO
Lasers Surg Med; 2009 Mar; 41(3):240-7. PubMed ID: 19291755
[TBL] [Abstract][Full Text] [Related]
15. Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.
Lapotko D
Nanomedicine (Lond); 2009 Oct; 4(7):813-45. PubMed ID: 19839816
[TBL] [Abstract][Full Text] [Related]
16. Plasmonic nanobubbles as tunable cellular probes for cancer theranostics.
Lapotko D
Cancers (Basel); 2011 Feb; 3(1):802-40. PubMed ID: 21442036
[TBL] [Abstract][Full Text] [Related]
17. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems.
Lukianova-Hleb EY; Ren X; Constantinou PE; Danysh BP; Shenefelt DL; Carson DD; Farach-Carson MC; Kulchitsky VA; Wu X; Wagner DS; Lapotko DO
PLoS One; 2012; 7(4):e34537. PubMed ID: 22509318
[TBL] [Abstract][Full Text] [Related]
18. Experimental retinal ablation using a fourth-harmonic 266 nm laser coupled with an optical fiber probe.
Yu PK; Miller J; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1587-93. PubMed ID: 16565396
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Nanobubble Formation: Gold Nanoparticle Conjugation to Qβ Virus-like Particles.
Parsamian P; Liu Y; Xie C; Chen Z; Kang P; Wijesundara YH; Al-Kharji NM; Ehrman RN; Trashi O; Randrianalisoa J; Zhu X; D'Souza M; Wilson LA; Kim MJ; Qin Z; Gassensmith JJ
ACS Nano; 2023 Apr; 17(8):7797-7805. PubMed ID: 36884260
[TBL] [Abstract][Full Text] [Related]
20. Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles.
Letfullin RR; Iversen CB; George TF
Nanomedicine; 2011 Apr; 7(2):137-45. PubMed ID: 20732456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
